9 / 1023
Quality beyond accuracy: are we failing to see the forest for the
trees? (Abs. 190-193)
Symposium
Targeting DNA repair / DDR pre-clinical evidence (Abs. 194-196)
New approaches in rectal cancer (Abs. 197-199)
Changing paradigm in the management of kidney cancer (Abs. 200-202)
Modern techniques for old indications (Abs. 203-205)
Quantitative imaging to individualise radiotherapy (Abs. 206-208)
Proffered Papers
Physics 5: Intra-fraction motion management I (Abs. 209-215)
Symposium
Head and neck: reduction of margins and side effects (Abs. 216-218)
The future of Radiation Oncology publishing: views through the Red
and Green telescopes (Abs. 219-221)
Poster Viewing
5: RTT (Abs. 222-230)
Symposium
QA in clinical trials: processes, impact and future perspectives
(Abs. 231-233)
Proffered Papers
Radiobiology 3: Novel targeting approaches in combination with
radiation (Abs. 234-238)
Clinical 5: Upper and lower GI (Abs. 239-244)
Clinical 6: Hadron therapy (Abs. 245-250)
Brachytherapy 3: Detectors and dose verification (Abs. 251-256)